Struggling to keep up with demand, some payers have responded by eliminating or restricting coverage
In May 2026, Lilly reported that in a late-stage trial of adults with obesity or overweight and at least one weight-related comorbidity, the highest 12 mg dose of retatrutide produced 28.3% average weight loss over 80 weeks, and more than 45% of participants lost 30% or more of their body weight
As a result, Medicaid coverage of GLP-1 drugs for obesity treatment is optional for states, while coverage for other indications (diabetes, cardiovascular disease, and sleep apnea) is required
Dietitians can help you plan meals to meet the daily requirements, like 80 to 100 grams of protein, 30 to 50 grams of fat, and 1,000 to 1,200 milligrams of calcium, which is particularly important for women